Embark Delta Inc. Completes New Product Shipment to Province of British Columbia

Toronto, Ontario--(Newsfile Corp. - April 20, 2021) -  Embark Delta Inc., a wholly owned subsidiary of Embark Health Inc. ("Embark" or the "Company") is pleased to announce the Company has successfully completed its second shipment of products to the British Columbia Liquor Distribution Branch ("BCLDB"), with Distilled + Infused Liquid Beverage Shots.

Cannot view this image? Visit: https://orders.newsfilecorp.com/files/7351/81000_69bf536174e98889_001.jpg

To view an enhanced version of this graphic, please visit:

Distilled + Infused is Embark's inaugural product offering in the beverage category. The suite of products under the Distilled + Infused brand are produced through Embark Nano's ground-breaking technology. The THC-infused Liquid Beverage Shot comes in an unflavoured option, which can be enjoyed with an adult's drink of choice. It also comes in strawberry lemonade and raspberry lemonade flavours which are naturally-flavoured. Packaged in a convenient "grab and go" option, all varieties contain Embark Nano's proprietary bitter blocker, which eliminates any bitter taste typically found in current market offerings. When combined with your preferred drink, the Liquid Beverage Shot results in a clear, translucent blend that won't compromise taste or flavour and requires no stirring. The Distilled + Infused Liquid Beverage Shot is ideal for those who desire an alternative to traditional cannabis consumption or beverage alternative to alcoholic beverages.

As with any alcoholic beverage and cannabis product, we recommend responsible consumption.

About Embark Health Inc.

Embark Health Inc. is a leader in solventless cannabis extraction, with a focus on the formulation and production of advanced 2.0 products for the B2B, medical, and adult-use markets. Embark continues to be at the forefront of production of concentrate products including bubble hash, traditional pressed hash, rosin, and dry sift. Building on Embark's strength in innovation and creating industry leading Cannabis 2.0 products, it recently announced new product offerings through its proprietary ground-breaking Embark Nano technology. The new suite of products coming to market include cannabis-infused beverages, topicals, edibles and water-soluble powders.

It is Embark's mandate to pursue best-in-class production processes resulting in premium quality commercial and consumer extraction products. Embark Health Inc. is dedicated to unleashing the full potential of the cannabis plant through scientific approaches to extraction and the production of quality products to enhance everyday life. For more information, please visit www.embarkhealthinc.com.

Investor Relations Contact:


This news release contains "forward-looking information" within the meaning of applicable securities laws including statements regarding the ability to leverage its existing Cannabis 2.0 products for the Canadian market, access to future markets, Embark's ability to increase production and offer new products and services following receipt of applicable licences, the continued business-to-business activities of Embark, and the effects of the aforementioned activities on the operational and financial condition of Embark. Although Embark believes in light of the estimates by management, current conditions and expected future developments and other factors, that the expectations reflected in this forward-looking information are reasonable, undue reliance should not be placed on them. Accordingly, Embark can give no assurance that they will prove to be correct. Actual results and developments may differ materially from those contemplated by these statements depending on, among other things, changes in economic conditions or financial markets; regulatory delays; increases in costs; litigation; legislative, environmental and other judicial, regulatory, political and competitive developments; and technological or operational difficulties. This list is not exhaustive of the factors that may affect our forward-looking information. The statements in this press release are made as of the date of this release. The Company assumes no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those reflected in the forward-looking statements unless and until required by securities laws applicable to the Company.


To view the source version of this press release, please visit https://www.newsfilecorp.com/release/81000